Part Details | DRONABINOL CAPSULES
6505-01-650-3812
Alternate Parts: NDC00051002121, NDC00051-0021-21, MARINOL, NDC00591359160, NDC00591-3591-60, 1389589, 6505NCM152492, NDC49884086702, NDC49884-0867-02, 6505-01-650-3812, 01-650-3812, 6505016503812, 016503812
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-650-3812
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00051-0021-21 | 6XMS3 | ABBVIE US LLC |
| MARINOL | 6XMS3 | ABBVIE US LLC |
| NDC00591-3591-60 | 6LMB8 | ACTAVIS PHARMA, INC. |
| 1389589 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM152492 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC49884-0867-02 | 0VZ14 | PAR PHARMACEUTICAL, INC.DBA PAR PHARMACEUTICAL |
Technical Data | NSN 6505-01-650-3812
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | DRONABINOL 2.5 MG CAPSULE 60S; FOR ORAL ADMINISTRATION; EACH CAPSULE CONTAINS: DRONABINOL 2.5 MG; DEA SCHEDULE III CONTROLLED SUBSTANCE; NON-USP; STORE IN A COOL ENVIRONMENT BETWEEN 8 AND 15 C (46 AND 59 F) AND ALTERNATIVELY COULD BE STORED IN A REFRIGERATOR |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | MARINOL 2.5 MG CAPSULE 60S |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE III |